Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis |
The Company’s assets and liabilities that were measured at fair value on a recurring basis were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value Measured as of December 31, 2022 |
|
Level 1 |
|
Level 2 |
|
Level 3 |
|
Total |
|
(In thousands) |
Assets |
|
|
|
|
|
|
|
Money market funds (i) |
$ |
31,728 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
31,728 |
|
U.S. Treasury securities (ii) |
24,701 |
|
|
— |
|
|
— |
|
|
24,701 |
|
Corporate bonds (ii) |
— |
|
|
23,513 |
|
|
— |
|
|
23,513 |
|
Total financial assets |
$ |
56,429 |
|
|
$ |
23,513 |
|
|
$ |
— |
|
|
$ |
79,942 |
|
Liabilities |
|
|
|
|
|
|
|
Common stock warrant liabilities (Public) (iii) |
$ |
1,748 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
1,748 |
|
Common stock warrant liabilities (Private Placement) (iii) |
— |
|
|
— |
|
|
888 |
|
|
888 |
|
Common stock warrant liabilities (2022 Private Warrant) (iii) |
— |
|
|
— |
|
|
109 |
|
|
109 |
|
Contingent earnout liabilities |
— |
|
|
— |
|
|
17,414 |
|
|
17,414 |
|
Total financial liabilities |
$ |
1,748 |
|
|
$ |
— |
|
|
$ |
18,411 |
|
|
$ |
20,159 |
|
|
|
|
|
|
|
|
|
|
Fair Value Measured as of December 31, 2021 |
|
Level 1 |
|
Level 2 |
|
Level 3 |
|
Total |
|
(In thousands) |
Assets |
|
|
|
|
|
|
|
Money market funds (i) |
$ |
207,471 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
207,471 |
|
U.S. Treasury securities (ii) |
8,141 |
|
|
— |
|
|
— |
|
|
8,141 |
|
Corporate bonds (ii) |
— |
|
|
7,342 |
|
|
— |
|
|
7,342 |
|
Total financial assets |
$ |
215,612 |
|
|
$ |
7,342 |
|
|
$ |
— |
|
|
$ |
222,954 |
|
Liabilities |
|
|
|
|
|
|
|
Common stock warrant liabilities (Public) (iii) |
$ |
14,318 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
14,318 |
|
Common stock warrant liabilities (Private Placement) (iii) |
— |
|
|
— |
|
|
7,387 |
|
|
7,387 |
|
Contingent earnout liabilities |
— |
|
|
— |
|
|
111,487 |
|
|
111,487 |
|
Total financial liabilities |
$ |
14,318 |
|
|
$ |
— |
|
|
$ |
118,874 |
|
|
$ |
133,192 |
|
(i) Included in cash and cash equivalents on the consolidated balance sheets.
(ii) Included in short-term investments on the consolidated balance sheets.
(iii) Included in warrant liabilities on the consolidated balance sheets.
|
Summary of Changes in Fair Value of Level 3 Financial Instruments |
The following table presents a summary of the changes in the fair value of the Company’s Level 3 financial instruments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable convertible preferred stock warrant liabilities |
|
Private placement warrant liabilities |
|
2022 Private Warrant |
|
Contingent earnout liabilities |
|
(In thousands) |
Fair value as of January 1, 2022 |
$ |
— |
|
|
$ |
7,387 |
|
|
$ |
— |
|
|
$ |
111,487 |
|
Issuance of warrants |
— |
|
|
— |
|
|
170 |
|
|
— |
|
Change in fair value |
— |
|
|
(6,499) |
|
|
(61) |
|
|
(94,073) |
|
Fair value as of December 31, 2022 |
$ |
—
|
|
|
$ |
888
|
|
|
$ |
109
|
|
|
$ |
17,414
|
|
|
|
Fair value as of January 1, 2021 |
$ |
181 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
Private placement warrant liabilities acquired as part of the reverse recapitalization |
— |
|
|
7,164 |
|
|
— |
|
|
— |
|
Contingent earnout liabilities recognized upon the closing of the reverse recapitalization |
— |
|
|
— |
|
|
— |
|
|
120,763 |
|
Change in fair value |
718 |
|
|
223 |
|
|
— |
|
|
(9,276) |
|
Exercise of warrants |
(899) |
|
|
— |
|
|
— |
|
|
— |
|
Fair value as of December 31, 2021 |
$ |
—
|
|
|
$ |
7,387
|
|
|
$ |
—
|
|
|
$ |
111,487
|
|
|